A comprehensive review by an international consortium of scientists has raised serious concerns about the COVID-19 mRNA vaccines’ safety profile.
Review articles are summaries of current research on a particular topic. They are also sometimes called literature reviews or secondary sources.
The review, “N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?” published on Science Direct, delves into the potential implications of a vaccine ingredient—N1-methyl-pseudouridine (m1Ψ)—that may play a role in immune suppression and cancer proliferation.
m1Ψ was incorporated into Pfizer-BioNTech’s COVID-19 mRNA vaccine to enhance its efficacy.
This component was introduced in the mRNA vaccine as a means to produce a significant amount of modified SARS-CoV-2 spike mRNA through in vitro transcription (IVT). This modification was crucial in the rapid development and deployment of the vaccine during the height of the pandemic.
However, the review article calls into question the long-term impacts of this modification, especially concerning the vaccine’s interaction with the body’s immune response and potential carcinogenic effects.
According to the review’s abstract, evidence suggests that while mRNA vaccines may have been “effective” in reducing severe disease outcomes, they might not provide sterilizing immunity, leaving individuals susceptible to recurring infections.
More critically, the review highlights that the inclusion of m1Ψ in mRNA vaccines appears to inhibit key immunological pathways, impairing the body’s early interferon signaling.
Interferon is a natural substance that helps the body’s immune system fight infection and other diseases, such as cancer.
1 comment:
I have worried that Princess Catherine has a turbo cancer caused by the vaccine program. She should have been a low risk candidate for an abdominal/gynecological/colon cancer (or whatever it is).
Post a Comment